On the strength of his stellar new Hollywood drama, Jay Kelly, Noah Baumbach understands this irony better than most.

Wondering if JPMorgan Chase is still worth considering after such a strong run, or if most of the upside is already priced in ...

BioNTech's latest narrative update reflects a slightly higher fair value estimate of about $138, tempered by a modestly increased discount rate of roughly 6.72%, as analysts balance confidence in the ...